Get Premium to unlock powerful stock data
Protagonist Therapeutics Inc logo

Protagonist Therapeutics Inc

$ 7.88 +0.11 (+1.42%) 10:30 AM EST
P/E:
At Loss
P/B:
1.22
Market Cap:
$ 383.41M
Enterprise V:
$ 78.59M
Volume:
150.67K
Avg Vol (2M):
1.38M
Also Trade In:
Volume:
150.67K
Market Cap $:
383.41M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.38M
Enterprise Value $:
78.59M
PB Ratio:
1.22
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Protagonist Therapeutics Inc
NAICS : 325412 SIC : 2834
7707 Gateway Boulevard, Suite 140, Newark, CA, USA, 94560
Description
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs.
Name Current Vs Industry Vs History
Cash-To-Debt 57.2
Equity-to-Asset 0.87
Debt-to-Equity 0.02
Debt-to-EBITDA -0.05
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 3.2
Distress
Grey
Safe
Beneish M-Score -2.52
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 22.69
9-Day RSI 21.74
14-Day RSI 22.39
6-1 Month Momentum % -44.76
12-1 Month Momentum % -38.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.86
Quick Ratio 7.86
Cash Ratio 7.03

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27.3

Financials (Next Earnings Date:2022-08-04 Est.)

PTGX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:PTGX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Performance
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 46.89
EPS (TTM) ($) -2.59
Beta 2.11
Volatility % 112.25
14-Day RSI 22.39
14-Day ATR ($) 1.135757
20-Day SMA ($) 9.943
12-1 Month Momentum % -38.51
52-Week Range ($) 7.49 - 50.54
Shares Outstanding (Mil) 48.66

Piotroski F-Score Details

Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Protagonist Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More